Back to search
Proliferative Diabetic Retinopathy - High Risk
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Proliferative Diabetic Retinopathy - High Risk trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Proliferative Diabetic Retinopathy - High Risk trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Patients with diabetic macular edema (DME) sometimes must undergo vitrectomy surgery (PPV) for diabetic and non-diabetic related issues. Patients may have impro…
Patients undergoing surgery for complications related to diabetes will be recruited.
The purpose of this Phase 4 study is to evaluate the safety of aflibercept 8mg in patients with proliferative diabetic retinopathy without center-involved diabe…
Proliferative diabetic retinopathy is a vision-threatening disease that can lead to irreversible visual loss. The treatment options for proliferative diabetic r…